Feed 600993.SS
60
Mayinglong Pharmaceutical Group Co., Ltd.
600993.SS · SHH
¥23.40 +0.52% (+¥0.12)
1M -1.48%
Market Cap ¥10.0B
P/E Ratio 17.24x
Div. Yield 3.01%
ROE 13.44%
Bulios Fair Price
¥31.11
32.9% upside
Current Price
¥23.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 600993.SS is currently undervalued relative to its market price. How does it work?
Valuation
70 /100
Cheap P/E 17.24x
EV/EBITDA 9.89x
P/S 2.59x
Growth
58 /100
Stable EPS growth 6.74%
Rev. growth 3.06%
FCF growth 21.71%
Profitability
83 /100
Strong Gross margin 49.19%
Net margin 15.04%
Op. margin 18.62%
Quality
70 /100
Excellent ROIC 13.14%
ROE 13.44%
ROA 10.70%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 4.96x
Int. coverage 97.07x
Stability
70 /100
Stable Beta 0.25x
Rev. volatility 15.03%
EPS volatility 13.48%
Ask StockBot about 600993.SS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Youzhang Xia
Employees
2,544
Headquarters
Wuhan